Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre

por Gould, Victoria M. W., Francis, James N., Anderson, Katie J., Georges, Bertrand, Cope, Alethea V., Tregoning, John S.
Publicado 2017

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection

por Brown, Damien P, Jones, Des C, Anderson, Katie J, Lapaque, Nicolas, Buerki, Robin A, Trowsdale, John, Allen, Rachel L
Publicado 2009

Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial

por Tasker, Sybil, Wight O’Rourke, Anna, Suyundikov, Anvar, Jackson Booth, Peta-Gay, Bart, Stephan, Krishnan, Vyjayanthi, Zhang, Jianfeng, Anderson, Katie J., Georges, Bertrand, Roberts, M. Scot
Publicado 2021